155 related articles for article (PubMed ID: 16325256)
1. Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies.
Shanafelt TD; Lee YK; Call TG; Nowakowski GS; Dingli D; Zent CS; Kay NE
Leuk Res; 2006 Jun; 30(6):707-12. PubMed ID: 16325256
[TBL] [Abstract][Full Text] [Related]
2. Natural products and the treatment of leukemia.
Hamblin T
Leuk Res; 2006 Jun; 30(6):649-50. PubMed ID: 16337269
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia.
Shanafelt TD; Call TG; Zent CS; LaPlant B; Bowen DA; Roos M; Secreto CR; Ghosh AK; Kabat BF; Lee MJ; Yang CS; Jelinek DF; Erlichman C; Kay NE
J Clin Oncol; 2009 Aug; 27(23):3808-14. PubMed ID: 19470922
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T-cell modulation by green tea in chronic lymphocytic leukemia.
D'Arena G; Simeon V; De Martino L; Statuto T; D'Auria F; Volpe S; Deaglio S; Maidecchi A; Mattoli L; Mercati V; Musto P; De Feo V
Int J Immunopathol Pharmacol; 2013; 26(1):117-25. PubMed ID: 23527714
[TBL] [Abstract][Full Text] [Related]
5. Green tea extract-patents and diversity of uses.
Saito ST; Gosmann G; Pungartnik C; Brendel M
Recent Pat Food Nutr Agric; 2009 Nov; 1(3):203-15. PubMed ID: 20653541
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.
Jung YD; Ellis LM
Int J Exp Pathol; 2001 Dec; 82(6):309-16. PubMed ID: 11846837
[TBL] [Abstract][Full Text] [Related]
7. Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities.
Elbling L; Weiss RM; Teufelhofer O; Uhl M; Knasmueller S; Schulte-Hermann R; Berger W; Micksche M
FASEB J; 2005 May; 19(7):807-9. PubMed ID: 15738004
[TBL] [Abstract][Full Text] [Related]
8. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
9. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.
Nishikawa T; Nakajima T; Moriguchi M; Jo M; Sekoguchi S; Ishii M; Takashima H; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
J Hepatol; 2006 Jun; 44(6):1074-82. PubMed ID: 16481065
[TBL] [Abstract][Full Text] [Related]
10. A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer.
Lazzeroni M; Guerrieri-Gonzaga A; Gandini S; Johansson H; Serrano D; Cazzaniga M; Aristarco V; Macis D; Mora S; Caldarella P; Pagani G; Pruneri G; Riva A; Petrangolini G; Morazzoni P; DeCensi A; Bonanni B
Cancer Prev Res (Phila); 2017 Jun; 10(6):363-370. PubMed ID: 28400479
[TBL] [Abstract][Full Text] [Related]
11. Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia.
Shanafelt TD; Call TG; Zent CS; Leis JF; LaPlant B; Bowen DA; Roos M; Laumann K; Ghosh AK; Lesnick C; Lee MJ; Yang CS; Jelinek DF; Erlichman C; Kay NE
Cancer; 2013 Jan; 119(2):363-70. PubMed ID: 22760587
[TBL] [Abstract][Full Text] [Related]
12. Green tea polyphenols for prostate cancer chemoprevention: a translational perspective.
Johnson JJ; Bailey HH; Mukhtar H
Phytomedicine; 2010 Jan; 17(1):3-13. PubMed ID: 19959000
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting the levels of tea polyphenols and caffeine in tea leaves.
Lin YS; Tsai YJ; Tsay JS; Lin JK
J Agric Food Chem; 2003 Mar; 51(7):1864-73. PubMed ID: 12643643
[TBL] [Abstract][Full Text] [Related]
14. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.
James KD; Forester SC; Lambert JD
Food Chem Toxicol; 2015 Feb; 76():103-8. PubMed ID: 25528115
[TBL] [Abstract][Full Text] [Related]
15. In vitro cytotoxicity of epigallocatechin gallate and tea extracts to cancerous and normal cells from the human oral cavity.
Weisburg JH; Weissman DB; Sedaghat T; Babich H
Basic Clin Pharmacol Toxicol; 2004 Oct; 95(4):191-200. PubMed ID: 15504155
[TBL] [Abstract][Full Text] [Related]
16. Clinical development plan: tea extracts. Green tea polyphenols. Epigallocatechin gallate.
J Cell Biochem Suppl; 1996; 26():236-57. PubMed ID: 9154181
[No Abstract] [Full Text] [Related]
17. Green tea polyphenol epigallocatechin-3-gallate attenuates TNF-α-induced intercellular adhesion molecule-1 expression and monocyte adhesion to retinal pigment epithelial cells.
Thichanpiang P; Wongprasert K
Am J Chin Med; 2015; 43(1):103-19. PubMed ID: 25644976
[TBL] [Abstract][Full Text] [Related]
18. The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells.
Sadava D; Whitlock E; Kane SE
Biochem Biophys Res Commun; 2007 Aug; 360(1):233-7. PubMed ID: 17585882
[TBL] [Abstract][Full Text] [Related]
19. The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial.
Dostal AM; Samavat H; Bedell S; Torkelson C; Wang R; Swenson K; Le C; Wu AH; Ursin G; Yuan JM; Kurzer MS
Food Chem Toxicol; 2015 Sep; 83():26-35. PubMed ID: 26051348
[TBL] [Abstract][Full Text] [Related]
20. Complementary therapies, herbs, and other OTC agents: Green tea (Camellia sinensis).
Cassileth B
Oncology (Williston Park); 2011 Dec; 25(14):1432-3. PubMed ID: 22329195
[No Abstract] [Full Text] [Related]
[Next] [New Search]
